Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)
Q1 2024 Earnings Call
May 08, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics Inc. Stock
€0.86
-4.040%
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 9 Buy predictions and 2 Sell predictions.
With a target price of 7 € there is potential for a 716.8% increase which would mean more than doubling the current price of 0.86 € for Karyopharm Therapeutics Inc..